ESCAMP Publications
  1. Baars EW, Kienle GS, Heusser P, Pedersen PA, van Wietmarschen HA, Kiene H, von Schön-Angerer T, Hamre HJ. Anthroposophic Medicinal Products: A literature review of reatures, similarities and differences to Conventional Medicinal Products, scientific and regulatory assessment. Global Adv Health Med 2022;11(1):1-17. DOI:

  2. Baars EW, Kiene H, Kienle GS, Heusser P, Hamre HJ. An assessment of the scientific status of anthroposophic medicine, applying criteria from the philosophy of science. Complement Ther Med 2018(40),145-150.

  3. Baars E, Koster E, Schoorel E. Client experiences with an integrated conventional and anthroposophic approach at the "Kindertherapeuticum" in Zeist. Merkurstab 2012;65(4):335-338.

  4. Baars EW, Hamre HJ. Whole medical systems versus the system of conventional biomedicine: a critical, narrative review of similarities, differences, and factors that promote the integration process. Evid Based Complement Alternat Med 2017

  5. Baars EW, Jong M, Nierop AF, Boers I, Savelkoul HF. Citrus/Cydonia compositum subcutaneous injections versus nasal spray for seasonal allergic rhinitis: a randomized controlled trial on efficacy and safety. ISRN Allergy 2011.

  6. Baars EW, Jong MC, Boers I, Nierop AF, Savelkoul HF. A comparative in vitro study of the effects of separate and combined products of Citrus e fructibus and Cydonia e fructibus on immunological parameters of seasonal allergic rhinitis. Mediators Inflamm 2012.

  7. Baars EW, Kooreman P. A 6-year comparative economic evaluation of healthcare costs and mortality rates of Dutch patients from conventional and CAM GPs. BMJ Open 2014;4(8):e005332.

  8. Baars EW, Koster EB, Verhoef J. The contribution of anthroposophic medicine to self-management: an exploration of concepts, evidence, and patient perspectives. Complement Med Res 2017;24(4):225-31.

  9. Baars EW, Nierop AF, Savelkoul HF. Development of systems biology-oriented biomarkers by permuted stepwise regression for the monitoring of seasonal allergic rhinitis treatment effects. J Immunol Methods 2012;378(1-2):62-71.

  10. Baars EW, Nierop AFM, and Savelkoul HFJ, Seasonal allergic rhinitis and systems biology-oriented biomarker discovery. In: (Preedy VR, Patel VB, editors) General methods in biomarker research and their application. Berlin: Springer, 2015. p. 1251-1275

  11. Baars EW. The benefit/risk balance of subcutaneous injections as used in homeopathy and anthroposophic medicine: A narrative literature review. Eur J Integr Med 2017;15:1-9.

  12. Hamre HJ, Glockmann A, Marti J, Soldner G. Mapping physicians’ experiences with medicinal products from whole medical systems: A descriptive analysis of the Vademecum of Anthroposophic Medicines. Complement Med Res 2020;

  13. Hamre HJ, Pham VN, Kern C, Rau R, Klasen J, Schendel U, Gerlach L, Drabik A, Simon L. A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs vs. conventional therapy including DMARDs for patients without preference. Patient Preference and Adherence 2018; 12: 375-97

  14. Hamre HJ, Glockmann A, Heckenbach K, Matthes H. Use and safety of anthroposophic medicinal products: an analysis of 44,662 patients from the EvaMed Pharmacovigilance Network. Drugs - Real World Outcomes 2017;4(4):199-213.

  15. Hamre HJ, Glockmann A, Schwarz R, Riley DS, Baars EW, Kiene H, et al. Antibiotic use in children with acute respiratory or ear infections: prospective observational comparison of anthroposophic and conventional treatment under routine primary care conditions. Evid Based Complement Alternat Med 2014.

  16. Hamre HJ, Kiene H, Glockmann A, Ziegler R, Kienle GS. Long-term outcomes of anthropo-sophic treatment for chronic disease: a four-year follow-up analysis of 1510 patients from a prospective observational study in routine outpatient settings. BMC Res Notes 2013;6(269).

  17. Hamre HJ, Kiene H, Ziegler R, Tröger W, Meinecke C, Schnürer C, et al. Overview of the publications from the Anthroposophic Medicine Outcomes Study (AMOS) - a whole system evaluation study. Global Adv Health Med 2014;3(1):54-70.

  18. Hamre HJ, Mittag I, Glockmann A, Kiene H, Tröger W. Pulpa dentis D30 for acute reversible pulpitis: A prospective cohort study in routine dental practice. Altern Ther Health Med 2011;17(1):16-21.

  19. Hamre HJ, Witt CM, Glockmann A, Ziegler R, Kienle GS, Willich SN, et al. Health costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients: a two-year prospective cohort study in anthroposophic outpatient settings. Eur J Health Econ 2010;11(1):77-94.

  20. Hamre HJ, Witt CM, Kienle GS, Glockmann A, Willich SN, Kiene H. Predictors of outcome after 6 and 12 months following anthroposophic therapy for adult outpatients with chronic disease: a secondary analysis from a prospective observational study. BMC Res Notes 2010;3(218).

  21. Hamre HJ, Witt CM, Kienle GS, Glockmann A, Ziegler R, Rivoir A, et al. Anthroposophic therapy for migraine: a two-year prospective cohort study in routine outpatient settings. Open Neurol J 2010;4:100-10.

  22. Hamre HJ, Witt CM, Kienle GS, Meinecke C, Glockmann A, Ziegler R, et al. Anthroposophic therapy for attention deficit hyperactivity: a two-year prospective study in outpatients. Int J Gen Med 2010;3:239-53.

  23. Hamre HJ. Scientific relevance of the Vademecum of Anthroposophic Medicines. Merkurstab 2018(2);71(2):120-4.

  24. Hamre HJ. Bedeutung des Vademecum-Projekts. Merkurstab, 2017;70(6):482-486.

  25. Jong MC, van Wietmarschen H, Glockmann A, Baars EW, Hamre HJ. Safety of Anthroposophic Medicinal Products: An analysis of adverse drug reactions from German pharmacovigilance databases. Drugs - Real World Outcomes 2021.

  26. Jong MC, Jong MU, Baars EW. Adverse drug reactions to anthroposophic and homeopathic solutions for injection: a systematic evaluation of German pharmacovigilance databases. Pharmacoepidemiol Drug Saf 2012;21(12):1295-301.

  27. Kiene H, Hamre HJ, Kienle GS. In support of clinical case reports: a system of causality assessment. Glob Adv Health Med 2013;2(2):64-75.

  28. Kienle GS, Albonico HU, Baars E, Hamre HJ, Zimmermann P, Kiene H. Anthroposophic medicine: an integrative medical system originating in Europe. Glob Adv Health Med 2013;2(6):20-31.

  29. Kienle GS, Albonico HU, Fischer L, Frei-Erb M, Hamre HJ, Heusser P, et al. Complementary therapy systems and their integrative evaluation. Explore (NY) 2011;7(3):175-87.

  30. Kienle GS, Glockmann A, Grugel R, Hamre HJ, Kiene H. Klinische Forschung zur Anthroposophischen Medizin - Update eines Health Technology Assessment-Berichts und Status Quo [Clinical research on anthroposophic medicine: update of a health technology assessment report and status quo]. Forsch Komplementärmed 2011:18; 269-82.

  31. Kienle GS, Hamre HJ, Kiene H, Ostermann T, Anderle L, Maussner N, et al. Methodological aspects of integrative and person-oriented health care evaluation. Complement Med Res 2017;24(Suppl 1):23-8.

  32. Kooreman P, Baars EW. Patients whose GP knows complementary medicine tend to have lower costs and live longer. Eur J Health Econ 2012;13(6):769-76.

  33. Koster EB, Ong RR, Heybroek R, Delnoij DM, Baars EW. The consumer quality index anthroposophic healthcare: a construction and validation study. BMC Health Serv Res 2014;14(1):148.

  34. Ponstein AS, Zwart CA, van Gerven M, Baars EW. The development of an anthroposophic, whole medical system, healthcare program for patients with depressive disorders. J Altern Compl Med (New York, NY) 2017.

  35. Wolf U, Winkler M, Ephraim M, Hamre HJ, Lemann D. The challenge of complexity: Anthroposophic and conventional medicine in dialogue. Primary Care 2011;11(10): 174-175.